Michelle MaskalyHomeU.S. is closer to first biosimilarFDA officials see no difference between Neupogen and the biosimilar version.January 10, 2015HomeType 2 Diabetes treatment market in Asia-Pacific to hit $10.5B by 2020The increasing diabetic population in India and China is the major reason behind the growth.January 8, 2015Previous PagePage 4 of 4